To these aims, the future of insulin therapy is directed toward two main areas: (1) the development of “intelligent insulins,” capable of auto-regulating their own levels according to glucose concentrations, or (2) the use and progress of artificial intelligence, exploiting its own learning capacity to provide decision support systems to further improve the treatment of diabetes. This evidence concerns the gene INS and diabetes mellitus.